Koyfin Home > Directory > Health Care > Acorda Therapeutics > Total Revenue

Acorda Therapeutics Total Revenue Chart (ACOR)

Acorda Therapeutics annual/quarterly Total Revenue from 2010 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Acorda Therapeutics Total Revenue for the quarter ending June 06, 2020 was $34m a -41.95% decrease of -14m year over year
  • Acorda Therapeutics Total Revenue for the last 12 months ending June 06, 2020 was $160m a -31.97% decrease of -51m year over year
  • Acorda Therapeutics Annual Total Revenue for 2019 was $192m a -145.02% decrease of -279m from 2018
  • Acorda Therapeutics Annual Total Revenue for 2018 was $471m a -24.79% decrease of -117m from 2017
  • Acorda Therapeutics Annual Total Revenue for 2017 was $588m a 11.68% increase of 69m from 2016
Other Income Statement Metrics:
  • Acorda Therapeutics EBITDA for the quarter ending December 12, 2018 was $-14m a 190.76% decrease of -26m year over year
  • Acorda Therapeutics Net Income for the quarter ending December 12, 2018 was $10m a 185.45% increase of 18m year over year
View Chart On Koyfin

Quarterly ACOR Total Revenue Data

06/2020$34m
03/2020$28m
12/2019$50m
09/2019$48m
06/2019$50m
03/2019$44m
12/2018$69m
09/2018$143m
06/2018$153m
03/2018$106m

Annual ACOR Total Revenue Data

2019$192m
2018$471m
2017$588m
2016$520m
2015$493m
2014$401m
2013$336m
2012$306m
2011$292m
2010$191m